These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34749804)

  • 1. The determinants of survival among adults with cystic fibrosis-a cohort study.
    Durda-Masny M; Goździk-Spychalska J; John A; Czaiński W; Stróżewska W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
    J Physiol Anthropol; 2021 Nov; 40(1):19. PubMed ID: 34749804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa, the type of mutation, lung function, and nutritional status in adults with cystic fibrosis.
    John A; Goździk-Spychalska J; Durda-Masny M; Czaiński W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
    Nutrition; 2021 Sep; 89():111221. PubMed ID: 33836428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
    Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
    PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
    Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
    Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum zinc concentration in cystic fibrosis patients with CFTR I1234V mutation associated with pancreatic sufficiency.
    AbdulWahab A; Abushahin A; Allangawi M; Chandra P; Abdel Rahman MO; Soliman A
    Clin Respir J; 2017 May; 11(3):305-310. PubMed ID: 26096753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.
    Rowe SM; Heltshe SL; Gonska T; Donaldson SH; Borowitz D; Gelfond D; Sagel SD; Khan U; Mayer-Hamblett N; Van Dalfsen JM; Joseloff E; Ramsey BW;
    Am J Respir Crit Care Med; 2014 Jul; 190(2):175-84. PubMed ID: 24927234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality in adults with cystic fibrosis.
    Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
    Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
    Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
    Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.
    Vongthilath R; Richaud Thiriez B; Dehillotte C; Lemonnier L; Guillien A; Degano B; Dalphin ML; Dalphin JC; Plésiat P
    PLoS One; 2019; 14(1):e0210201. PubMed ID: 30620748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Real-world effectiveness of ivacaftor in children with cystic fibrosis and the G551D mutation].
    Gomez-Pastrana D; Nwokoro C; McLean M; Brown S; Christiansen N; Pao CS
    An Pediatr (Engl Ed); 2019 Mar; 90(3):148-156. PubMed ID: 30093322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
    Millar BC; McCaughan J; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Feb; 43(1):92-100. PubMed ID: 29293275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pancreatic status, CFTR mutations, Staphylococcus aureus and/or Pseudomonas aeruginosa infection/colonization on lung function in cystic fibrosis during a 2-year follow-up period.
    Pascoal MA; Marson FAL; Paschoal IA; Levy CE
    Wien Klin Wochenschr; 2020 Oct; 132(19-20):572-580. PubMed ID: 32356101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.
    Levy H; Kalish LA; Cannon CL; García KC; Gerard C; Goldmann D; Pier GB; Weiss ST; Colin AA
    Pediatr Pulmonol; 2008 May; 43(5):463-71. PubMed ID: 18361452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CFTR genotype as a predictor of prognosis in cystic fibrosis.
    McKone EF; Goss CH; Aitken ML
    Chest; 2006 Nov; 130(5):1441-7. PubMed ID: 17099022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis.
    Keating CL; Liu X; Dimango EA
    Chest; 2010 May; 137(5):1157-63. PubMed ID: 19965956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of radiographic and clinical characteristics of low-risk and high-risk cystic fibrosis genotypes.
    Ferril GR; Nick JA; Getz AE; Barham HP; Saavedra MT; Taylor-Cousar JL; Nichols DP; Curran-Everett D; Kingdom TT; Ramakrishnan VR
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):915-20. PubMed ID: 25224556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.